NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

Can Analyst Optimism on Authentication Tech Redefine RealReal’s (REAL) Edge in Luxury Resale?

In recent days, several Wall Street analysts have upgraded their outlook on The RealReal, expressing optimism about the company’s revenue growth and market positioning ahead of its upcoming September-quarter earnings report. This renewed analyst confidence comes as RealReal continues to expand its reach in the luxury resale market, underpinned by expectations for higher consignment and direct revenue streams. Much of the analyst optimism is rooted in RealReal's ability to leverage...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Pharmaceutical (BMRN): Fresh Valuation Insights Following Raised Guidance and Product Momentum

BioMarin Pharmaceutical (BMRN) recently delivered its third quarter results, demonstrating ongoing revenue growth led by strong uptake of VOXZOGO and PALYNZIQ. The company also nudged its full-year revenue guidance higher, signaling steady confidence. See our latest analysis for BioMarin Pharmaceutical. Despite an encouraging run of product successes, including the FDA’s acceptance of PALYNZIQ for expanded review and a modestly raised revenue forecast, BioMarin’s share price has had a tough...